NZ214482A - Glycoprotein antibody complex immunotoxin against target cell ribosomes - Google Patents

Glycoprotein antibody complex immunotoxin against target cell ribosomes

Info

Publication number
NZ214482A
NZ214482A NZ214482A NZ21448285A NZ214482A NZ 214482 A NZ214482 A NZ 214482A NZ 214482 A NZ214482 A NZ 214482A NZ 21448285 A NZ21448285 A NZ 21448285A NZ 214482 A NZ214482 A NZ 214482A
Authority
NZ
New Zealand
Prior art keywords
target cell
antibody complex
against target
glycoprotein antibody
cell ribosomes
Prior art date
Application number
NZ214482A
Inventor
F Jansen
P Gros
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NZ214482A publication Critical patent/NZ214482A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Prolonged-acting immunotoxin consisting of a conjugate in which an antibody or antibody fragment is coupled, via a covalent structure containing a disulphide group or a thioether group, to a ribosome-inactivating glycoprotein having a prolonged action obtained by oxidation of its saccharide moieties with periodate ions.
NZ214482A 1985-02-13 1985-12-09 Glycoprotein antibody complex immunotoxin against target cell ribosomes NZ214482A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8502068A FR2577135B1 (en) 1985-02-13 1985-02-13 LONG-TERM ACTION IMMUNOTOXINS COMPRISING A GLYCOPEPTITIDE CONSTITUENT MODIFYING RIBOSOMES MODIFIED ON ITS POLYSACCHARIDE PATTERNS

Publications (1)

Publication Number Publication Date
NZ214482A true NZ214482A (en) 1989-08-29

Family

ID=9316241

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ214482A NZ214482A (en) 1985-02-13 1985-12-09 Glycoprotein antibody complex immunotoxin against target cell ribosomes

Country Status (14)

Country Link
EP (1) EP0192002B1 (en)
JP (1) JPH0725701B2 (en)
KR (1) KR930003333B1 (en)
AT (1) ATE75487T1 (en)
AU (1) AU591077B2 (en)
CA (1) CA1264667A (en)
DE (1) DE3585951D1 (en)
DK (1) DK563585A (en)
FR (1) FR2577135B1 (en)
GR (1) GR852914B (en)
IE (1) IE59909B1 (en)
NZ (1) NZ214482A (en)
PT (1) PT81623B (en)
ZA (1) ZA859299B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566271B1 (en) * 1984-06-20 1986-11-07 Sanofi Sa NOVEL CYTOTOXIC CONJUGATES FOR USE IN THERAPEUTICS AND PROCESS FOR OBTAINING SAME
FR2573656B1 (en) * 1984-11-29 1987-02-27 Sanofi Sa MEDICINAL PRODUCT COMPRISING A COMBINATION OF AT LEAST ONE IMMUNOTOXIN AND AT LEAST ONE MANNOSE-CONTAINING POLYMER
WO1988006451A1 (en) * 1987-02-24 1988-09-07 Xoma Corporation Immunosuppression in immunotoxin based human therapy
US4981979A (en) * 1987-09-10 1991-01-01 Neorx Corporation Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
IT1249051B (en) * 1991-02-26 1995-02-11 Italfarmaco Spa IMMUNOTOXIN FROM ANTI-CD5 MONOCLONAL ANTIBODIES
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47372A (en) * 1975-05-27 1979-10-31 Yeda Res & Dev Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same
FR2437213A1 (en) * 1978-09-28 1980-04-25 Cm Ind CYTOTOXIC PRODUCTS FORMED BY COVALENT BINDING OF THE CHAIN TO RICIN WITH AN ANTIBODY AND THEIR PREPARATION METHOD
JPS5616418A (en) * 1979-07-20 1981-02-17 Teijin Ltd Antitumor protein complex and its preparation
EP0044167A3 (en) * 1980-07-14 1982-04-21 The Regents Of The University Of California Antibody targeted cytotoxic agent
FR2504010B1 (en) * 1981-04-15 1985-10-25 Sanofi Sa ANTI-CANCER MEDICINAL PRODUCTS CONTAINING THE RICIN-ASSOCIATED CHAIN ASSOCIATED WITH ANTIMELANOMA ANTIBODY AND PROCESS FOR THEIR PREPARATION
JPS5843926A (en) * 1981-09-08 1983-03-14 Suntory Ltd Selective carcinostatic agent
FR2516794B1 (en) * 1981-11-20 1985-10-25 Sanofi Sa NOVEL CANCER DRUGS FOR THE TREATMENT OF LEUKEMIA T CONTAINING RICIN AND A SPECIFIC MONOCLONAL ANTIBODY
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
PT80662B (en) * 1984-06-20 1986-12-09 Sanofi Sa Process to obtain anti-tumoral glycoprotein modified on its glycidic portions

Also Published As

Publication number Publication date
AU5078385A (en) 1986-08-14
FR2577135A1 (en) 1986-08-14
JPH0725701B2 (en) 1995-03-22
ATE75487T1 (en) 1992-05-15
DE3585951D1 (en) 1992-06-04
IE59909B1 (en) 1994-04-20
FR2577135B1 (en) 1989-12-15
DK563585D0 (en) 1985-12-05
AU591077B2 (en) 1989-11-30
PT81623A (en) 1986-01-01
DK563585A (en) 1986-08-14
KR930003333B1 (en) 1993-04-26
CA1264667A (en) 1990-01-23
KR860006482A (en) 1986-09-11
EP0192002A1 (en) 1986-08-27
GR852914B (en) 1986-04-07
ZA859299B (en) 1986-08-27
PT81623B (en) 1988-04-21
JPS61200925A (en) 1986-09-05
IE853071L (en) 1986-08-13
EP0192002B1 (en) 1992-04-29

Similar Documents

Publication Publication Date Title
NZ214482A (en) Glycoprotein antibody complex immunotoxin against target cell ribosomes
BE877407A (en) CUTTING MECHANISM BY HARVESTER-CHOPPER
EP0121388A3 (en) Immunoglobulin conjugates
AU549495B2 (en) Immunoglobulin-vindesine conjugates
DE3689620D1 (en) DNA MODIFIED BY CYS CODON.
FR2509255B1 (en)
ES2043609T3 (en) INTERLEUKIN-2 COMPOSITIONS.
DK543087D0 (en) PROCEDURE FOR THE PREPARATION OF 2,6-DI-TERT.BUTYL-4-MERCAPTOPHENOL AND PROCEDURE FOR THE PREPARATION OF AN INTERMEDIATE APPLICABLE
NZ228105A (en) Antihypertensive hyperimmune milk, its production and medicaments therefrom
EP0248040A4 (en) Ricin-antibody conjugates.
GR851497B (en)
EP0640614A3 (en) Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates.
EP0601318A3 (en) Process for production of a conjugate from a specific binding partner and a carbohydrate containing protein.
PT8108Y (en) MODULAR COVERAGE ELEMENT
ES253149U (en) Lighter-opener set (Machine-translation by Google Translate, not legally binding)
EP0273519A3 (en) Process for the preparation of a modified elastomeric polymer
Moskalenko et al. Study of relationship between the light-harvesting complex B 800-850 to the H-subunit of the reaction center in sulfur photosynthetic bacterium Chromatium minutissimum chromatophores.
ES8206973A1 (en) Disaggregated Solutions of Polypeptides
EP0199203A3 (en) Lamp with an elongated hollow reflector
EP0275926A3 (en) Photo-product energy barrier composition
ES265430U (en) Perfected cut for covers. (Machine-translation by Google Translate, not legally binding)
IT8509410A0 (en) RAREFIED GAS ILLUMINATING TUBE, INCLUDING INTERMEDIATE ELECTRODES SUITABLE TO COOPERATE WITH END ELECTRODES
ES280916U (en) Perfected tubular unión collector (Machine-translation by Google Translate, not legally binding)
ES529345A0 (en) IMPROVEMENTS INTRODUCED IN THE PURPOSE OF THE MAIN PATENT NUM. 522,260, BY: FOCAL OR CONCENTRATION COLLECTOR, OF SOLAR RADIATION
ES254814U (en) Modular strip for packaging protection (Machine-translation by Google Translate, not legally binding)